Difference between revisions of "Hemolytic uremic syndrome"

From Libre Pathology
Jump to navigation Jump to search
m (format)
(wikify)
Line 13: Line 13:
*TTP is the main (clinical) DDx of HUS.
*TTP is the main (clinical) DDx of HUS.
**It is classically characterized by: microangiopathic hemolytic anemia, thrombocytopenia, fever, mild renal failure, and prominent neurologic symptoms.
**It is classically characterized by: microangiopathic hemolytic anemia, thrombocytopenia, fever, mild renal failure, and prominent neurologic symptoms.
*Both are classified as ''thrombotic microangiopathies''.<ref>URL: [http://emedicine.medscape.com/article/779218-overview http://emedicine.medscape.com/article/779218-overview]. Accessed on: 8 September 2010.</ref>
*Both are classified as ''[[thrombotic microangiopathies]]''.<ref>URL: [http://emedicine.medscape.com/article/779218-overview http://emedicine.medscape.com/article/779218-overview]. Accessed on: 8 September 2010.</ref>


==See also==
==See also==

Revision as of 03:51, 9 November 2010

Hemolytic uremic syndrome, abbreviated HUS, is the triad of:[1]

  • Microangiopathic hemolytic anemia.
    • Microangiopathic = disease affecting small blood vessels.[2]
  • Thrombocytopenia = low platelet count.
  • Acute renal failure.

Etiology

  • Rare (uncooked) hamburger.
  • E. coli serotype O157:H7.
    • Verotoxins from E. coli O157:H7 --> endothelial injury.[3]

Relation to thrombotic thrombocytopenic purpura (TTP)

  • TTP is the main (clinical) DDx of HUS.
    • It is classically characterized by: microangiopathic hemolytic anemia, thrombocytopenia, fever, mild renal failure, and prominent neurologic symptoms.
  • Both are classified as thrombotic microangiopathies.[4]

See also

References

  1. URL: http://emedicine.medscape.com/article/779218-overview. Accessed on: 8 September 2010.
  2. URL: http://www.mercksource.com/pp/us/cns/cns_hl_dorlands_split.jsp?pg=/ppdocs/us/common/dorlands/dorland/one/000005089.htm. Accessed on: 9 September 2010.
  3. Petruzziello TN, Mawji IA, Khan M, Marsden PA (February 2009). "Verotoxin biology: molecular events in vascular endothelial injury". Kidney Int. Suppl. (112): S17–9. doi:10.1038/ki.2008.612. PMID 19180125.
  4. URL: http://emedicine.medscape.com/article/779218-overview. Accessed on: 8 September 2010.